About
Jake Becraft is a synthetic biologist and entrepreneur, and Co-Founder and CEO of Strand Therapeutics, where he also serves on the Board of Directors. Working with colleagues at MIT's Synthetic Biology Center, he led the development of a synthetic biology programming language for mRNA. He holds a Ph.D. in Biological Engineering and Synthetic Biology from MIT and a B.S. in Chemical and Biomolecular Engineering from the University of Illinois at Urbana-Champaign.
Invests in
Biotech
Experience
- Strand TherapeuticsCo-Founder and CEOcurrent2017 — presentCambridge, MA
- Starlight VenturesInvestment Advisorcurrent2019 — present
- Public Health UnitedExecutive Board Member, Director of Fundraising2018 — 2020
Education
- Massachusetts Institute of TechnologyDoctor of Philosophy (Ph.D.), Biological Engineering2013 — 2019
- University of Illinois Urbana-ChampaignBachelor of Science (B.S.), Chemical and Biomolecular Engineering2009 — 2013
Skills & more
Chemistry28NMR spectroscopy5NMR3UV/Vis3Chemical Engineering18Cell Culture4HPLCData Analysis3Spectroscopy3Research16Organic Chemistry3Biochemistry5
+7 more
CharacterizationScanning Electron MicroscopyUV/Vis SpectroscopyMatlabPerlMicrosoft OfficeMathematica- 2017 Science Alliance Leadership Training (SALT) Fellow of the New York Academy of Sciences — The New York Academy of Sciences
From Jake's professional profile.
Investments
Board seats
Strand Therapeutics
Per the firm's website.
Colleagues at Alix Ventures
Amee Kapadia
Investor at Alix Ventures
Brian Fiske
SAB Member - Drug Development at Alix Ventures
Chas Pulido
Founder & General Partner at Alix Ventures
Daniel Delubac
SAB Member - Diagnostics/Lab Services at Alix Ventures
Dennis Gong
Investor at Alix Ventures
Eric Dai
Investor at Alix Ventures
Gia Oscherwitz
Investor at Alix Ventures
Jessica DeVilla
Investor at Alix Ventures